Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

Background and purposeBiologic therapies are anticipated to dominate the treatment landscape for neuromyelitis optica spectrum disorders (NMOSD) in the future. Despite this, many patients in China continue to use off-label medications due to economic and other constraints. A multicenter NMOSD cohort...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Zhou, Xiaolin Yang, Xinyi Wang, Bin Li, Yun Xu, Haoran Zhang, Yinxin Zhu, Xiaoming Wang, Jinzhou Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Neurology
Subjects:
neuromyelitis optica spectrum disorder
off-label
traditional immunosuppressants
rituximab
economy
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1559118/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1559118/full

Similar Items